FHD-286 is a potent and selective ATPase inhibitor of the SWI/SNF chromatin remodeling complex subunits BRM (SMARCA2) and BRG1 (SMARCA4). It serves as a valuable chemical probe for investigating BAF complex dysfunction in diseases, supporting both in vitro mechanistic studies and in vivo research in models of acute myeloid leukemia.
Molekulargewicht:
562.66
Reinheit:
99.73% (May vary between batches)
CAS Nummer:
[2671128-05-3]
Formel:
C24H30N6O6S2
Target-Kategorie:
Epigenetic Reader Domain,OXPHOS
Anwendungsbeschreibung:
Solubility: DMSO:245 mg/mL (435.43 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten